<DOC>
	<DOCNO>NCT01387776</DOCNO>
	<brief_summary>This study evaluation benefit 1 st Trimester risk marker detect Early Onset Pre-eclampsia use Placental Growth factor ( PIGF ) potential marker Trisomy 21 aneuploidy . Aim prospective nonprofit study analyze benefit early onset pre eclampsia risk assessment 1st trimester ( measure biochemical marker [ PIGF ] , blood pressure Doppler ultrasound ) , result permit modify influence course preeclampsia pregnancy . The investigator also evaluate potential use PIGF marker improve prenatal screen currently use nuchal translucency , serum Pregnancy-associated plasma protein A ( PAPP-A ) free beta subunit human chorionic gonadotropin ( fBhCG ) parameter .</brief_summary>
	<brief_title>Detecting Early Onset Pre-eclampsia Use Placental Growth Factor ( PlGF ) Marker Trisomy 21</brief_title>
	<detailed_description />
	<mesh_term>Pre-Eclampsia</mesh_term>
	<mesh_term>Eclampsia</mesh_term>
	<mesh_term>Trisomy</mesh_term>
	<mesh_term>Down Syndrome</mesh_term>
	<mesh_term>Mitogens</mesh_term>
	<criteria>Singleton pregnancy Nulliparous pregnancy Gestation age 6.013.6 week last menstrual period verify ultrasound Blood sample provide gestational age 6.013.6 week Informed Consent Multifetal pregnancy Primiparous multiparous pregnancy Mental retardation mental disorder impose doubt regard true patient 's willingness participate study Gestation age 6.0 13.6 week last menstrual period verify ultrasound . Lack blood sample specify enrollment period Known major fetal anomaly fetal demise Lack demographic data</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>